Emma Sampson

Emma Sampson

Higher Degree by Research Candidate

Adelaide Medical School

Faculty of Health and Medical Sciences

My research centres around the biological underpinnings of psychiatric illness, especially Major Depressive Disorder. Specifically, I am particularly interested in the relationship between MDD and neuroinflammation in the brain, and the potential of anti-inflammatory treatment to ameliorate psychiatric symptoms.

    Expand

  • Appointments
    Date Position Institution name
    2020 - 2020 Standard Marking (Biological Psychiatry) The University of Adelaide
    2019 - 2020 Research assistant, Cognitive and Emotional Recovery Training Program for Depression (CERT-D) study The University of Adelaide

  • Education
    Date Institution name Country Title
    2011 - 2015 University of Adelaide Australia Bachelor of Arts
    2010 - 2016 The University of Adelaide Australia Bachelor of Health Sciences (Honours)

  • Postgraduate Training
    Date Title Institution Country
    2017 Analysis of symptomatic and biological changes in Major Depressive Disorder related to co-administered antidepressant and anti-inflammatory treatment The University of Adelaide Australia

  • Research Interests
    Gene Expression Immunology Mental Health Neurosciences Psychiatry Neuroscience, Behaviour and Brain Health
    Expand

  • Journals
    Year Citation
    2021 Mills, N. T., Sampson, E., Fourrier, C., & Baune, B. T. (2021). Clinical switching strategies of various antidepressants to Vortioxetine in the PREDDICT trial. The international journal of neuropsychopharmacology, 24(4), 314-321.
    DOI Scopus2 WoS2
    2021 Knight, M. J., Lyrtzis, E., Fourrier, C., Aboustate, N., Sampson, E., Hori, H., . . . Baune, B. T. (2021). Psychological training to improve psychosocial function in patients with major depressive disorder: A randomised clinical trial. Psychiatry Research, 300, 7 pages.
    DOI Scopus1 WoS1
    2021 Baune, B. T., Sampson, E., Louise, J., Hori, H., Schubert, K. O., Clark, S. R., . . . Fourrier, C. (2021). No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial.. Eur Neuropsychopharmacol, 53, 34-46.
    DOI
    2020 Fourrier, C., Sampson, E., Hori, H., Schubert, K. O., Clark, S., Mills, N. T., & Baune, B. T. (2020). Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status. Brain, Behavior, and Immunity, 88, 242-251.
    DOI Scopus3 WoS3 Europe PMC1
    2019 Knight, M. J., Fourrier, C., Lyrtzis, E., Aboustate, N., Sampson, E., Hori, H., . . . Baune, B. T. (2019). Cognitive deficits in the THINC-integrated tool (THINC-it) are associated with psychosocial dysfunction in patients with major depressive disorder. Journal of Clinical Psychiatry, 80(1), 18m12472-1-18m12472-8.
    DOI Scopus8 WoS3 Europe PMC1
    2018 Fourrier, C., Sampson, E., Mills, N. T., & Baune, B. T. (2018). Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Trials, 19(1), 447-1-447-14.
    DOI Scopus24 WoS22 Europe PMC8
    Expand

  • Committee Memberships
    Date Role Committee Institution Country
    2020 - ongoing Vice-President Health Sciences Postgraduate Association (HeSPA) Committee The University of Adelaide Australia
    2019 - 2020 Member Health Sciences Postgraduate Association (HeSPA) Committee The University of Adelaide Australia
    2018 - 2018 Member Biological Psychiatry Australia’s 8th Annual Scientific Meeting Local Organising Committee Biological Psychiatry Australia Australia
    2017 - 2018 Member SAHMRI Student Association Committee SAHMRI Australia
Connect With Me
External Profiles